Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
Details for Australian Patent Application No. 2002314043 (hide)
International Classifications
Event Publications
2 January 2003 Complete Application Filed
Priority application(s): 01111109.3 08.05.01 EP
1 May 2003 Application Open to Public Inspection
Published as AU-B-2002314043
19 April 2007 Application Accepted
Published as AU-B-2002314043
30 August 2007 Standard Patent Sealed
10 June 2010 Alteration of Name
The name of the patentee has been altered to LTS Lohmann Therapie-Systeme AG; UCB Pharma GmbH 2003
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002314044-Novel use of 2-phenyl-substituted imidazotriazinones
2002314042-COMPOSITE BOARDS WITH HOLLOW CHAMBERS AND METHOD OF PRODUCTION
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser